Background and Details of the Action
The Company had previously communicated on July 30, 2026, regarding a notice received from the NPPA on July 29, 2026. The notice alleged overcharging under the Drugs (Prices Control) Order, 2013 (DPCO, 2013) for the product Symbicort Turbuhaler 160/4.5 (Inhaler).
The initial show cause notice from the NPPA was dated September 11, 2025, followed by a subsequent reminder. The allegation specifically concerns the period from May 2016 to November 2025.
The Company challenged the NPPA's demand before the Hon'ble High Court of Delhi.
Current Development and Order Details
The Hon'ble High Court of Delhi passed an order on October 29, 2026. The order directs the NPPA that no coercive steps be taken against the Company in this matter until the next date of hearing.
The date of receipt of this court order was October 30, 2026.
The next date of hearing in the matter is scheduled for January 11, 2027.
Financial Impact
The total monetary demand from the NPPA that has been temporarily stayed is approximately ₹151,19,66,035 (One Hundred Fifty One Crore Nineteen Lakh Sixty Six Thousand and Thirty Five Rupees). This amount is comprised of the alleged overcharged amount and interest accrued up to October 30, 2026.
The court's order has a direct financial impact by preventing the NPPA from taking coercive action to recover this amount until at least the next hearing on January 11, 2027.